Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when UNCY files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsUnicycive reports full year 2025 financial results and business update
Filed March 30, 2026 · Period ending March 30, 2026 · ~1 min read
Key Changes
-
medium
Company issued press release announcing financial results for the year ended December 31, 2025, along with a business update. Actual financial figures and operational details are contained in the attached press release rather than the 8-K body.
Item 2.02 verify on EDGAR →
Summary
Unicycive Therapeutics filed an 8-K on March 30, 2026 to announce its full year 2025 financial results and provide a business update. This is a standard earnings announcement where the company uses the 8-K filing to formally disclose the release of financial information, with the substantive details contained in the attached press release rather than in the filing itself. Retail investors should review the attached press release (Exhibit 99.1) for the actual financial figures, year-over-year comparisons, and management commentary on business developments.
The 8-K filing serves primarily as the formal SEC notification mechanism.
Section-by-Section Diff
Event · Item 2.02 — Results of Operations and Financial Condition
Item 2.02 — Results of Operations and Financial Condition filed; see Key Changes for terms.
Added in current filing · verify on EDGAR →
On March 30, 2026, Unicycive Therapeutics, Inc. issued a press release announcing its financial results for the full year ended December 31, 2025 and provided a business update.
The company disclosed its financial results for the full year ended December 31, 2025 through a press release. The 8-K filing itself does not contain the actual financial figures or business update details, as these are furnished in the attached press release exhibit. This is a standard earnings announcement filing where the substantive information is in the press release rather than the 8-K body.
Event · Item 9.01 — Financial Statements and Exhibits
Unicycive filed an 8-K attaching a press release dated March 30, 2026; no material event details disclosed in the filing body.
Show 1 minor / wording change
Added in current filing · verify on EDGAR →
99.1 Press Release of Unicycive Therapeutics, Inc. dated March 30, 2026.
The 8-K references an attached press release dated March 30, 2026. The filing body does not disclose the content or subject matter of the press release, so the nature and materiality of the event cannot be determined from this 8-K alone.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Jun 8, 2026 · How we verify